9th Circ. To Hear Args In Psilocybin Rescheduling Challenge
A Ninth Circuit panel will hear oral arguments Friday on whether the U.S. Drug Enforcement Administration erred when it said that psilocybin, the active ingredient in psychedelic mushrooms, had no medical...To view the full article, register now.
Already a subscriber? Click here to view full article